首页 > 最新文献

Europasian Journal of Medical Sciences最新文献

英文 中文
Covering Letter 求职信
Pub Date : 2020-08-23 DOI: 10.46405/ejms.v1i1.151
Ejms Journals
COvering Letter
求职信
{"title":"Covering Letter","authors":"Ejms Journals","doi":"10.46405/ejms.v1i1.151","DOIUrl":"https://doi.org/10.46405/ejms.v1i1.151","url":null,"abstract":"COvering Letter","PeriodicalId":254508,"journal":{"name":"Europasian Journal of Medical Sciences","volume":"115 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-08-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123072160","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Citation Style 引用样式
Pub Date : 2020-08-23 DOI: 10.46405/ejms.v1i1.155
Ejms Journals
Citation Style
引用样式
{"title":"Citation Style","authors":"Ejms Journals","doi":"10.46405/ejms.v1i1.155","DOIUrl":"https://doi.org/10.46405/ejms.v1i1.155","url":null,"abstract":"Citation Style","PeriodicalId":254508,"journal":{"name":"Europasian Journal of Medical Sciences","volume":"15 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-08-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116738089","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Toxicity Profiles of Commonly Used Anti-Inflammatory Drugs in Geriatrics 老年医学常用抗炎药的毒性分析
Pub Date : 2020-07-29 DOI: 10.46405/ejms.v2i2.107
Talal Alhouzani, Mohammad Saleem, S. Khadka, Saleh Musaed Mohammed Al-Subari, D. Shrestha, Imamah Anwar Butt
Anti-inflammatory drugs are among the mostly used drugs in geriatrics. Geriatrics usually encounter problems of pain and inflammation and are more vulnerable to the toxicity of drugs as compared to young patients. In this review, we aimed to find out the toxic profile of drugs and the pharmacotherapy considerations for geriatric care. The diseases geriatrics mostly suffered from are osteoarthritis (OA), ankylosing spondylitis, carcinoma, and other degenerative disorders that require anti-inflammatory medicines. Non-steroidal anti-inflammatory drugs (NSAIDs) and corticosteroids are mostly used agents for the treatment of inflammation in geriatrics. Due to the over the counter (OTC) availability, NSAIDs are mostly used and being self-medicated as well. As the pharmacokinetics of drugs get altered due to alteration in body physiology in geriatrics, the pharmacodynamics also gets affected, and hence toxicity ensues even with normal dose. Depending upon the nature of the drugs; gastrointestinal, renal, and cardiovascular toxicities occur. Due to this reason, utmost care should be taken for pharmacotherapy practice in such population. The presence of comorbidity and poly-pharmacy will complicate drug therapy. The drugs should be used for the shortest duration possible at the lowest effective dose, and with careful surveillance to monitor toxicities. The careful evaluation of the beneficial and potential risks of the agents must be considered for pharmacotherapy practice in such populations.
抗炎药是老年医学中最常用的药物之一。与年轻患者相比,老年患者通常会遇到疼痛和炎症问题,并且更容易受到药物毒性的影响。在这篇综述中,我们的目的是找出药物的毒性特征和老年护理的药物治疗注意事项。老年人最常患的疾病是骨关节炎(OA)、强直性脊柱炎、癌和其他需要抗炎药物的退行性疾病。非甾体类抗炎药(NSAIDs)和皮质类固醇是治疗老年炎症的常用药物。由于非处方药(OTC)的可用性,非甾体抗炎药大多被使用和自我治疗。由于老年患者机体生理机能的改变,药物的药代动力学发生改变,药效学也受到影响,因此即使在正常剂量下也会产生毒性。视乎药物的性质;发生胃肠道、肾脏和心血管毒性。由于这个原因,在这类人群中进行药物治疗时应格外小心。合并症和多重用药的存在将使药物治疗复杂化。这些药物应在最短的时间内以最低的有效剂量使用,并仔细监测毒性。在这类人群的药物治疗实践中,必须仔细评估药物的有益和潜在风险。
{"title":"Toxicity Profiles of Commonly Used Anti-Inflammatory Drugs in Geriatrics","authors":"Talal Alhouzani, Mohammad Saleem, S. Khadka, Saleh Musaed Mohammed Al-Subari, D. Shrestha, Imamah Anwar Butt","doi":"10.46405/ejms.v2i2.107","DOIUrl":"https://doi.org/10.46405/ejms.v2i2.107","url":null,"abstract":"Anti-inflammatory drugs are among the mostly used drugs in geriatrics. Geriatrics usually encounter problems of pain and inflammation and are more vulnerable to the toxicity of drugs as compared to young patients. In this review, we aimed to find out the toxic profile of drugs and the pharmacotherapy considerations for geriatric care. The diseases geriatrics mostly suffered from are osteoarthritis (OA), ankylosing spondylitis, carcinoma, and other degenerative disorders that require anti-inflammatory medicines. Non-steroidal anti-inflammatory drugs (NSAIDs) and corticosteroids are mostly used agents for the treatment of inflammation in geriatrics. Due to the over the counter (OTC) availability, NSAIDs are mostly used and being self-medicated as well. As the pharmacokinetics of drugs get altered due to alteration in body physiology in geriatrics, the pharmacodynamics also gets affected, and hence toxicity ensues even with normal dose. Depending upon the nature of the drugs; gastrointestinal, renal, and cardiovascular toxicities occur. Due to this reason, utmost care should be taken for pharmacotherapy practice in such population. The presence of comorbidity and poly-pharmacy will complicate drug therapy. The drugs should be used for the shortest duration possible at the lowest effective dose, and with careful surveillance to monitor toxicities. The careful evaluation of the beneficial and potential risks of the agents must be considered for pharmacotherapy practice in such populations.","PeriodicalId":254508,"journal":{"name":"Europasian Journal of Medical Sciences","volume":"80 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126179983","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Knowledge regarding COVID-19 among Registered Nurses of Pokhara, Nepal 尼泊尔博卡拉注册护士关于COVID-19的知识
Pub Date : 2020-07-19 DOI: 10.46405/ejms.v2i2.88
Akriti Kafle, Sirjana Pandit Pahari, S. Khanal, Kushalata Baral, Kabita Pathak, S. Baral, Anil Kafle, Maginsh Dahal
Background: Coronavirus disease is an emerging pandemic disease. The whole world is suffering from this disease these days. It is an acute respiratory disease in which transmission occurs essentially through respiratory droplets and this virus said to have 2-14 days of incubation.Objective: To assess their knowledge regarding COVID19 among registered nurses of Pokhara valley.Methods: A descriptive cross-sectional study was performed with the help of the pretested and self-administered questionnaires to 750 registered nurses of Pokhara valley. Thus collected data was entered into SPSS version 20 and then further analyzed using R software. Frequency, percentages, the mean and standard deviation were calculated for the analysis. p-value was calculated where ever applicable to find the significance of data.Results: The study disclosed that mass of the respondents had moderate proportion (44.8%) concerning understanding, followed by the respondents had a low level of knowledge (29.2%) and the rest of them (26.0%) had good knowledge about COVID 19.Conclusion: Overall knowledge among nurses was found to be satisfactory as the disease is entirely new. Further research and updates on the diseases will help to profound knowledge among nurses.
背景:冠状病毒病是一种新兴的大流行疾病。这些天全世界都在遭受这种疾病的折磨。它是一种急性呼吸道疾病,主要通过呼吸道飞沫传播,这种病毒据说有2-14天的潜伏期。目的:了解博卡拉谷地注册护士对新冠肺炎相关知识的了解情况。方法:采用预测问卷和自填问卷对博卡拉山谷地区750名注册护士进行描述性横断面研究。将收集到的数据输入到SPSS version 20中,然后使用R软件进行进一步分析。计算频率、百分比、平均值和标准差进行分析。在适用的地方计算p值,以发现数据的显著性。结果:调查显示,大部分受访者对新冠肺炎的了解程度中等(44.8%),其次是低水平(29.2%),其余受访者对新冠肺炎的了解程度较好(26.0%)。结论:由于该病是一种全新的疾病,护理人员对该病的总体了解情况令人满意。对这些疾病的进一步研究和更新将有助于加深护士的知识。
{"title":"Knowledge regarding COVID-19 among Registered Nurses of Pokhara, Nepal","authors":"Akriti Kafle, Sirjana Pandit Pahari, S. Khanal, Kushalata Baral, Kabita Pathak, S. Baral, Anil Kafle, Maginsh Dahal","doi":"10.46405/ejms.v2i2.88","DOIUrl":"https://doi.org/10.46405/ejms.v2i2.88","url":null,"abstract":"Background: Coronavirus disease is an emerging pandemic disease. The whole world is suffering from this disease these days. It is an acute respiratory disease in which transmission occurs essentially through respiratory droplets and this virus said to have 2-14 days of incubation.Objective: To assess their knowledge regarding COVID19 among registered nurses of Pokhara valley.Methods: A descriptive cross-sectional study was performed with the help of the pretested and self-administered questionnaires to 750 registered nurses of Pokhara valley. Thus collected data was entered into SPSS version 20 and then further analyzed using R software. Frequency, percentages, the mean and standard deviation were calculated for the analysis. p-value was calculated where ever applicable to find the significance of data.Results: The study disclosed that mass of the respondents had moderate proportion (44.8%) concerning understanding, followed by the respondents had a low level of knowledge (29.2%) and the rest of them (26.0%) had good knowledge about COVID 19.Conclusion: Overall knowledge among nurses was found to be satisfactory as the disease is entirely new. Further research and updates on the diseases will help to profound knowledge among nurses.","PeriodicalId":254508,"journal":{"name":"Europasian Journal of Medical Sciences","volume":"84 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-07-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116469153","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
Access to Maternal Health Services during COVID-19 在COVID-19期间获得孕产妇保健服务
Pub Date : 2020-07-08 DOI: 10.46405/ejms.v2i2.110
S. Pant, Saugat Koirala, M. Subedi
Most causes of maternal morbidity and mortality can be prevented by giving prompt, suitable treatment to the women by qualified health practitioners. Maternal health services (MHS), which include antenatal care, delivery care, and postnatal care, can play a crucial role in preventing maternal health problems. The recent coronavirus disease (COVID-19) pandemic has had a disastrous effect on the health care delivery system of people of all ages, on a global scale but pregnant women face particular challenges. The aim of this review is to assess the effect of COVID-19 on access to MHS. For writing this narrative review, national and international reports on maternal health services during COVID-19, along with journal articles on the related topic were reviewed. Due to this pandemic, women worldwide are facing more barriers to accessing maternal health care, including restrictions, transport challenges, and anxiety over possibly being exposed to coronavirus. Many women preferred not to seek healthcare due to the fear of themselves being infected with the virus or transmitting it to their unborn babies. Additionally, movement restriction has made it difficult for many pregnant women to reach health care facilities. Even those who managed to reach health facilities have reported not receiving timely care. As a result, a considerable rise in maternal mortality globally has been estimated over the next six months. Despite the circumstances, efforts have been made to boost maternal health in both developed and developing countries. This pandemic has highlighted the importance of health preparedness with special attention given to vulnerable people like pregnant women and newborns while planning for such events.Keywords: Childbirth, COVID19, Maternal Health, Pandemic, Pregnancy, Women’s health
产妇发病和死亡的大多数原因可以通过由合格的保健人员向妇女提供及时、适当的治疗来预防。孕产妇保健服务(MHS)包括产前护理、分娩护理和产后护理,可在预防孕产妇保健问题方面发挥关键作用。最近的冠状病毒病(COVID-19)大流行在全球范围内对所有年龄段人群的卫生保健服务系统造成了灾难性影响,但孕妇面临着特殊挑战。本综述的目的是评估COVID-19对获得MHS的影响。为编写这一叙述性审查,审查了关于COVID-19期间孕产妇保健服务的国家和国际报告以及相关主题的期刊文章。由于这次大流行,世界各地的妇女在获得孕产妇保健方面面临更多障碍,包括限制、交通挑战以及对可能接触冠状病毒的焦虑。由于担心自己感染病毒或将其传染给未出生的婴儿,许多妇女宁愿不寻求医疗保健。此外,行动受限使许多孕妇难以到达保健设施。即使那些设法到达卫生设施的人也报告说没有得到及时的护理。因此,估计今后6个月全球孕产妇死亡率将大幅上升。尽管情况如此,发达国家和发展中国家都在努力促进产妇保健。这次大流行突出了卫生准备的重要性,在规划此类事件时应特别关注孕妇和新生儿等弱势群体。关键词:分娩,covid - 19,孕产妇保健,大流行,妊娠,妇女健康
{"title":"Access to Maternal Health Services during COVID-19","authors":"S. Pant, Saugat Koirala, M. Subedi","doi":"10.46405/ejms.v2i2.110","DOIUrl":"https://doi.org/10.46405/ejms.v2i2.110","url":null,"abstract":"Most causes of maternal morbidity and mortality can be prevented by giving prompt, suitable treatment to the women by qualified health practitioners. Maternal health services (MHS), which include antenatal care, delivery care, and postnatal care, can play a crucial role in preventing maternal health problems. The recent coronavirus disease (COVID-19) pandemic has had a disastrous effect on the health care delivery system of people of all ages, on a global scale but pregnant women face particular challenges. The aim of this review is to assess the effect of COVID-19 on access to MHS. For writing this narrative review, national and international reports on maternal health services during COVID-19, along with journal articles on the related topic were reviewed. Due to this pandemic, women worldwide are facing more barriers to accessing maternal health care, including restrictions, transport challenges, and anxiety over possibly being exposed to coronavirus. Many women preferred not to seek healthcare due to the fear of themselves being infected with the virus or transmitting it to their unborn babies. Additionally, movement restriction has made it difficult for many pregnant women to reach health care facilities. Even those who managed to reach health facilities have reported not receiving timely care. As a result, a considerable rise in maternal mortality globally has been estimated over the next six months. Despite the circumstances, efforts have been made to boost maternal health in both developed and developing countries. This pandemic has highlighted the importance of health preparedness with special attention given to vulnerable people like pregnant women and newborns while planning for such events.\u0000\u0000Keywords: Childbirth, COVID19, Maternal Health, Pandemic, Pregnancy, Women’s health","PeriodicalId":254508,"journal":{"name":"Europasian Journal of Medical Sciences","volume":"69 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123412050","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 63
Hydroxychloroquine with or without macrolide and standard of care versus standard of care alone for COVID-19 cases: a systematic review and meta-analysis 羟氯喹加或不加大环内酯和标准治疗与单独使用标准治疗对COVID-19病例的影响:系统评价和荟萃分析
Pub Date : 2020-07-07 DOI: 10.21203/rs.3.rs-39092/v1
D. Shrestha, P. Budhathoki, S. Khadka, Era Rawal
Background: Coronavirus disease (COVID-19) pandemic has been a global health threat. The specific treatment of this disease has not yet been approved. In this review, we aimed at assessing the role of hydroxychloroquine with/without macrolide in terms of efficacy and adverse effects against the standard of care. Methods: Pubmed, Medline, Google Scholar, Cochrane Library, and Clinicaltrials.gov were searched for the quantitative and qualitative synthesis of 13 studies using PRISMA guidelines for a proper review. Assessment of heterogeneity was done using the I-squared (I2) test and fixed/random effect analysis was done to determine the odds/risk ratio among the selected studies.Results: Meta-analysis of our study demonstrated no significant differences in improvement for the virological cure (RR 0.95, 0.67-1.34), whereas a significant relationship was there in radiological progression (pneumonia resolution) (RR 1.40, 1.03-1.91) between the two arms. There are 1.52 times the odds of intubation during treatment (CI 0.61-3.77), 1.08 times the risk of mortality (CI 0.65-1.79), and about 2.21 times increased risk of development of adverse effect (OR 2.21, 0.95-5.17). Though overall it is of no statistical significance, clinical relevance to thinking while using the treatment for COVID-19 is advised. Among randomized controlled trials, the treatment group has 3.5 times (OR 3.48, 1.64-7.42) higher risk of developing adverse effects. There is 2.5 times the likelihood of severe arrhythmias and QT prolongation (OR 2.49, 1.67-3.70) on the treatment arm compared to control.Conclusion: Hydroxychloroquine with/without macrolide has shown no beneficial effect in viral clearance, survival rates while shows significant relation with the radiological improvement compared to standard of care but may increase the risk of intubation, overall side effects, and cardiac complications like arrhythmias and QT prolongation. Thus utilizing this treatment needs to be judged in clinical relevance and proper monitoring.
背景:冠状病毒病(COVID-19)大流行已成为全球健康威胁。这种疾病的具体治疗方法尚未得到批准。在这篇综述中,我们旨在评估羟氯喹加/不加大环内酯的疗效和不良反应对标准护理的影响。方法:检索Pubmed、Medline、Google Scholar、Cochrane Library和Clinicaltrials.gov,根据PRISMA指南对13项研究进行定量和定性综合评价。异质性评估采用I-squared (I2)检验,固定/随机效应分析确定所选研究的几率/风险比。结果:本研究的荟萃分析显示,两组患者在病毒学治疗方面的改善无显著差异(RR 0.95, 0.67-1.34),而在放射学进展(肺炎消退)方面存在显著相关性(RR 1.40, 1.03-1.91)。治疗期间插管的几率为1.52倍(CI 0.61 ~ 3.77),死亡风险为1.08倍(CI 0.65 ~ 1.79),不良反应发生风险增加约2.21倍(OR 2.21, 0.95 ~ 5.17)。虽然总体上没有统计学意义,但建议在使用COVID-19治疗时思考的临床相关性。在随机对照试验中,治疗组发生不良反应的风险是对照组的3.5倍(OR 3.48, 1.64-7.42)。治疗组发生严重心律失常和QT间期延长的可能性是对照组的2.5倍(OR 2.49, 1.67-3.70)。结论:与标准治疗相比,羟氯喹加/不加大环内酯对病毒清除率、生存率无显著影响,但与放射学改善有显著关系,但可能增加插管、总体副作用和心律失常、QT间期延长等心脏并发症的风险。因此,使用这种治疗需要判断临床相关性和适当的监测。
{"title":"Hydroxychloroquine with or without macrolide and standard of care versus standard of care alone for COVID-19 cases: a systematic review and meta-analysis","authors":"D. Shrestha, P. Budhathoki, S. Khadka, Era Rawal","doi":"10.21203/rs.3.rs-39092/v1","DOIUrl":"https://doi.org/10.21203/rs.3.rs-39092/v1","url":null,"abstract":"\u0000 Background: Coronavirus disease (COVID-19) pandemic has been a global health threat. The specific treatment of this disease has not yet been approved. In this review, we aimed at assessing the role of hydroxychloroquine with/without macrolide in terms of efficacy and adverse effects against the standard of care. Methods: Pubmed, Medline, Google Scholar, Cochrane Library, and Clinicaltrials.gov were searched for the quantitative and qualitative synthesis of 13 studies using PRISMA guidelines for a proper review. Assessment of heterogeneity was done using the I-squared (I2) test and fixed/random effect analysis was done to determine the odds/risk ratio among the selected studies.Results: Meta-analysis of our study demonstrated no significant differences in improvement for the virological cure (RR 0.95, 0.67-1.34), whereas a significant relationship was there in radiological progression (pneumonia resolution) (RR 1.40, 1.03-1.91) between the two arms. There are 1.52 times the odds of intubation during treatment (CI 0.61-3.77), 1.08 times the risk of mortality (CI 0.65-1.79), and about 2.21 times increased risk of development of adverse effect (OR 2.21, 0.95-5.17). Though overall it is of no statistical significance, clinical relevance to thinking while using the treatment for COVID-19 is advised. Among randomized controlled trials, the treatment group has 3.5 times (OR 3.48, 1.64-7.42) higher risk of developing adverse effects. There is 2.5 times the likelihood of severe arrhythmias and QT prolongation (OR 2.49, 1.67-3.70) on the treatment arm compared to control.Conclusion: Hydroxychloroquine with/without macrolide has shown no beneficial effect in viral clearance, survival rates while shows significant relation with the radiological improvement compared to standard of care but may increase the risk of intubation, overall side effects, and cardiac complications like arrhythmias and QT prolongation. Thus utilizing this treatment needs to be judged in clinical relevance and proper monitoring.","PeriodicalId":254508,"journal":{"name":"Europasian Journal of Medical Sciences","volume":"109 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128542605","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Mental Health Implications of COVID-19 in Kenya COVID-19对肯尼亚精神健康的影响
Pub Date : 2020-07-04 DOI: 10.46405/ejms.v2i2.111
Marylyn Ochillo, I. Elsie
Dear Editor, As the COVID-19 pandemic continues to spread rapidly worldwide, it is certainly having an immense effect on the mental wellbeing of people thereby increasing the number of people with elevated levels of stress, depression, or anxiety.1 Developing countries will undoubtedly have serious mental health implications due to the poor or almost non-existent mental health services. In Kenya, mental health is still somewhat neglected mainly because only 0.05% of the Governments’s health budget allocation goes to mental health.2 The allocated health budget largely focuses on communicable diseases despite the impact of mental health on the Kenyan population. Although there are no accurate data on the prevalence of mental disorders in Kenya, various studies have shown that the prevalence of depression generally varies from 19% in household review studies2 to 42% among the general population visiting the health facilities.3 Similar to other African countries, Kenya has a shortage of mental health professionals. Mathari hospital is the country’s only mental referral facility where one nurse handles up to 150 patients.4 In a country with only approximately 100 psychiatrists serving a population of 45 million, only a third of the psychiatrists work in the government health facilities.5 The rest of the psychiatrists work in private health facilities that are generally more expensive making them inaccessible to the majority of the population due to the unaffordable consultation fees.
随着COVID-19大流行继续在全球迅速蔓延,它无疑对人们的心理健康产生了巨大影响,从而增加了压力、抑郁或焦虑水平升高的人数发展中国家由于缺乏或几乎不存在精神卫生服务,无疑会对精神卫生造成严重影响。在肯尼亚,心理健康仍然受到一定程度的忽视,主要原因是政府的卫生预算拨款中只有0.05%用于心理健康尽管精神健康对肯尼亚人口有影响,但已分配的卫生预算主要侧重于传染病。虽然没有关于肯尼亚精神障碍流行率的准确数据,但各种研究表明,在家庭审查研究中,抑郁症的流行率从19%到42%不等与其他非洲国家一样,肯尼亚也缺乏精神卫生专业人员。3 .马萨里医院是该国唯一的精神病院,一名护士可处理多达150名病人在一个只有大约100名精神科医生为4 500万人口服务的国家,只有三分之一的精神科医生在政府卫生机构工作其余的精神科医生在私人医疗机构工作,这些医疗机构的费用普遍较高,大多数人由于负担不起咨询费而无法前往。
{"title":"Mental Health Implications of COVID-19 in Kenya","authors":"Marylyn Ochillo, I. Elsie","doi":"10.46405/ejms.v2i2.111","DOIUrl":"https://doi.org/10.46405/ejms.v2i2.111","url":null,"abstract":"Dear Editor, \u0000As the COVID-19 pandemic continues to spread rapidly worldwide, it is certainly having an immense effect on the mental wellbeing of people thereby increasing the number of people with elevated levels of stress, depression, or anxiety.1 Developing countries will undoubtedly have serious mental health implications due to the poor or almost non-existent mental health services. \u0000In Kenya, mental health is still somewhat neglected mainly because only 0.05% of the Governments’s health budget allocation goes to mental health.2 The allocated health budget largely focuses on communicable diseases despite the impact of mental health on the Kenyan population. Although there are no accurate data on the prevalence of mental disorders in Kenya, various studies have shown that the prevalence of depression generally varies from 19% in household review studies2 to 42% among the general population visiting the health facilities.3 Similar to other African countries, Kenya has a shortage of mental health professionals. Mathari hospital is the country’s only mental referral facility where one nurse handles up to 150 patients.4 In a country with only approximately 100 psychiatrists serving a population of 45 million, only a third of the psychiatrists work in the government health facilities.5 The rest of the psychiatrists work in private health facilities that are generally more expensive making them inaccessible to the majority of the population due to the unaffordable consultation fees.","PeriodicalId":254508,"journal":{"name":"Europasian Journal of Medical Sciences","volume":"206 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115579846","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Mental Health Concern during COVID-19 Pandemic in Nepal 尼泊尔COVID-19大流行期间的精神卫生问题
Pub Date : 2020-07-04 DOI: 10.46405/ejms.v2i2.87
A. Chalise, S. Paudel
The whole world struggles to combat COVID-19 pandemic forcing nations to take extreme measures in an attempt to prevent outbreaks and save lives. It has been noted that COVID-19 has established itself as a risk factor for psychological distress among the population of different subgroups. There are several factors such as uncertainties, controversies, misinformation, social isolation, stigma, and discrimination which are escalating the risk of massive mental distress among the public. Nepal is trying to increase its effort to combat COVID-19 by adopting community containment measures, but the mental health of the frontline health workforce, service providers, and the general public seems to be highly overshadowed. In this aspect, this paper aims to shed light on different aspects of mental health issues emerging in Nepal during the time of COVID-19 lockdown, along with some of its potential contributing factors. Nepal lacks adequate infrastructure and human resource to provide mental healthcare services effectively in case of any massive mental distress. In this state of resource deprivation, providing education and training regarding psychosocial issues to health system leaders, first responders, and health care professionals could be a key to address the population need at present and to prevent further complications.
全世界都在与COVID-19大流行作斗争,迫使各国采取极端措施,试图防止疫情爆发和拯救生命。值得注意的是,COVID-19已成为不同亚群体人口中心理困扰的风险因素。不确定性、争议、错误信息、社会孤立、污名化和歧视等因素加剧了公众遭受大规模精神痛苦的风险。尼泊尔正试图通过采取社区遏制措施来加大抗击COVID-19的力度,但一线卫生工作者、服务提供者和公众的心理健康状况似乎被严重忽视。在这方面,本文旨在揭示尼泊尔在COVID-19封锁期间出现的心理健康问题的不同方面,以及一些潜在的影响因素。尼泊尔缺乏足够的基础设施和人力资源,无法在出现大规模精神痛苦时有效地提供精神保健服务。在这种资源匮乏的情况下,向卫生系统领导人、急救人员和卫生保健专业人员提供有关社会心理问题的教育和培训,可能是解决目前人口需求和防止进一步并发症的关键。
{"title":"Mental Health Concern during COVID-19 Pandemic in Nepal","authors":"A. Chalise, S. Paudel","doi":"10.46405/ejms.v2i2.87","DOIUrl":"https://doi.org/10.46405/ejms.v2i2.87","url":null,"abstract":"The whole world struggles to combat COVID-19 pandemic forcing nations to take extreme measures in an attempt to prevent outbreaks and save lives. It has been noted that COVID-19 has established itself as a risk factor for psychological distress among the population of different subgroups. There are several factors such as uncertainties, controversies, misinformation, social isolation, stigma, and discrimination which are escalating the risk of massive mental distress among the public. Nepal is trying to increase its effort to combat COVID-19 by adopting community containment measures, but the mental health of the frontline health workforce, service providers, and the general public seems to be highly overshadowed. In this aspect, this paper aims to shed light on different aspects of mental health issues emerging in Nepal during the time of COVID-19 lockdown, along with some of its potential contributing factors. Nepal lacks adequate infrastructure and human resource to provide mental healthcare services effectively in case of any massive mental distress. In this state of resource deprivation, providing education and training regarding psychosocial issues to health system leaders, first responders, and health care professionals could be a key to address the population need at present and to prevent further complications.","PeriodicalId":254508,"journal":{"name":"Europasian Journal of Medical Sciences","volume":"120 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132711777","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Grammar and Spelling Checker 语法和拼写检查
Pub Date : 2020-05-31 DOI: 10.46405/ejms.v1i1.84
Europasian Journals
Paste the contents here to check the grammar and spelling.
把内容粘贴在这里检查语法和拼写。
{"title":"Grammar and Spelling Checker","authors":"Europasian Journals","doi":"10.46405/ejms.v1i1.84","DOIUrl":"https://doi.org/10.46405/ejms.v1i1.84","url":null,"abstract":"Paste the contents here \u0000to check the grammar and spelling.","PeriodicalId":254508,"journal":{"name":"Europasian Journal of Medical Sciences","volume":"398 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123270711","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Successful Pregnancy after Previous Uterine Rupture 子宫破裂后成功怀孕
Pub Date : 2020-03-03 DOI: 10.46405/ejms.v2i1.22
K. Tiwari, A. Karki, G. Dangal, H. Pradhan, R. Shrestha, K. Bhattachan, Rekha Paudel, N. Bajracharya, S. Bharati
Uterine rupture is a rare and catastrophic incidence with high maternal and fetal morbidity rates. It is most commonly seen in the scarred uterus. The unscarred uterus is least susceptible to rupture with the incidencebeing 1 in 8000 deliveries. In the past, pregnancy after uterine rupture was not widely advised and patients underwent hysterectomy or tubal ligation but with the evolving practice, women are motivated for pregnancy which can be successful with proper obstetric care and emphasis on time and mode of delivery. Here we present a case of 31 years old female, gravida-2 para-1 living 0 with previous uterine rupture after medical induction of labor with stillbirth 4 years ago. She underwent emergency laparotomy with the repair. The patient spontaneously conceived and had close antenatal care throughout the pregnancy. The patient was admitted at 34 weeks of gestation and kept under close surveillance. Corticosteroid was administered. She underwent spontaneous labor at 37 weeks of gestation and emergency cesarean section was planned, delivered via a breech presentation to a live baby of 2.4 kg, APGAR score of 8/10, 9/10 at 1 and 5 minutes.
子宫破裂是一种罕见的灾难性事件,具有很高的母婴发病率。最常见于瘢痕子宫。无疤痕子宫最不容易破裂,发生率为1 / 8000。在过去,子宫破裂后怀孕并不被广泛建议,患者接受子宫切除术或输卵管结扎,但随着实践的发展,妇女有动力怀孕,通过适当的产科护理和重视分娩的时间和方式,怀孕可以成功。我们报告一例31岁女性,妊娠2期1活0岁,4年前药物引产后子宫破裂伴死产。她接受了紧急剖腹手术进行修复。患者自发怀孕,并在整个怀孕期间进行了密切的产前护理。患者在妊娠34周时入院并接受密切监测。给予皮质类固醇。她在妊娠37周自然分娩,并计划紧急剖宫产,通过臀位分娩,活婴2.4 kg, 1分钟和5分钟APGAR评分分别为8/ 10,9 /10。
{"title":"Successful Pregnancy after Previous Uterine Rupture","authors":"K. Tiwari, A. Karki, G. Dangal, H. Pradhan, R. Shrestha, K. Bhattachan, Rekha Paudel, N. Bajracharya, S. Bharati","doi":"10.46405/ejms.v2i1.22","DOIUrl":"https://doi.org/10.46405/ejms.v2i1.22","url":null,"abstract":"Uterine rupture is a rare and catastrophic incidence with high maternal and fetal morbidity rates. It is most commonly seen in the scarred uterus. The unscarred uterus is least susceptible to rupture with the incidencebeing 1 in 8000 deliveries. In the past, pregnancy after uterine rupture was not widely advised and patients underwent hysterectomy or tubal ligation but with the evolving practice, women are motivated for pregnancy which can be successful with proper obstetric care and emphasis on time and mode of delivery. Here we present a case of 31 years old female, gravida-2 para-1 living 0 with previous uterine rupture after medical induction of labor with stillbirth 4 years ago. She underwent emergency laparotomy with the repair. The patient spontaneously conceived and had close antenatal care throughout the pregnancy. The patient was admitted at 34 weeks of gestation and kept under close surveillance. Corticosteroid was administered. She underwent spontaneous labor at 37 weeks of gestation and emergency cesarean section was planned, delivered via a breech presentation to a live baby of 2.4 kg, APGAR score of 8/10, 9/10 at 1 and 5 minutes.","PeriodicalId":254508,"journal":{"name":"Europasian Journal of Medical Sciences","volume":"8 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-03-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114733724","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
期刊
Europasian Journal of Medical Sciences
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1